推荐产品
一般描述
Methylation of cytosines located 5′ to guanosine is known to have a profound effect on the expression of many eukaryotic genes. In normal cells methylation occurs predominantly in CG-poor regions, while CG-rich areas, called CpG-islands remain unmethylated. The exceptions are the extensive methylation of CpG islands associated with transcriptional inactivation of regulatory regions of imprinted genes and genes on the inactive X-chromosome of females. Aberrant methylation of normally unmethylated CpG islands has been documented as a relatively frequent event in immortalized and transformed cells and has been associated with transcriptional inactivation of defined tumor suppresser genes in human cancers (7, 8). Hundreds of CpG islands are now known to exhibit the characteristic of hypermethylation in tumors.
Several methods have been developed to determine the methylation status of cytosine. These include digestion with methylation sensitive restriction enzymes as in restriction landmark genomic scanning, oligonucleotide arrays, bisulfite genomic DNA sequencing and Methylation Specific PCR (MSP). Some techniques are more useful for discovery while others are better used for monitoring of known methylated cytosines. Genomic DNA sequencing, although time consuming and labor intensive, offers a more universal detection method. MSP is now an established technology for the monitoring of abnormal gene methylation in selected gene sequences. Utilizing small amounts of DNA, this procedure offers sensitive and specific detection of 5-methylcytosine in promoters. It is being exploited to define tumor suppresser gene function, and to provide a new strategy for early tumor detection.
The initial step of both bisulfite genomic sequencing and MSP is to perform a bisulfite modification of the DNA sample. MSP then involves PCR amplification with specific primers designed to distinguish methylated from unmethylated DNA. The CpGenome Fast DNA Modification Kit contains the reagents for the initial bisulfite modification of the DNA required for both methodologies.
Several methods have been developed to determine the methylation status of cytosine. These include digestion with methylation sensitive restriction enzymes as in restriction landmark genomic scanning, oligonucleotide arrays, bisulfite genomic DNA sequencing and Methylation Specific PCR (MSP). Some techniques are more useful for discovery while others are better used for monitoring of known methylated cytosines. Genomic DNA sequencing, although time consuming and labor intensive, offers a more universal detection method. MSP is now an established technology for the monitoring of abnormal gene methylation in selected gene sequences. Utilizing small amounts of DNA, this procedure offers sensitive and specific detection of 5-methylcytosine in promoters. It is being exploited to define tumor suppresser gene function, and to provide a new strategy for early tumor detection.
The initial step of both bisulfite genomic sequencing and MSP is to perform a bisulfite modification of the DNA sample. MSP then involves PCR amplification with specific primers designed to distinguish methylated from unmethylated DNA. The CpGenome Fast DNA Modification Kit contains the reagents for the initial bisulfite modification of the DNA required for both methodologies.
The CpGenome Fast DNA Modification Kit contains reagents required to perform a bisulfite modification on a DNA sample including DNA isolation columns for easy and efficient recovery of bisulfite treated DNA.
应用
For MSP primer design, please use the MethPrime software package. Click here
The CpGenome Fast DNA Modification Kit contains the reagents for the initial bisulfite modification of the DNA required for both methodologies.
包装
25 samples
组分
90584 DNA Modification Reagent 6 g Room Temp
90585 Binding Buffer 20 mL Room Temp
90586 Wash Buffer* 12 mL Room Temp
90587 Elution Buffer 1.5 mL Room Temp
90588 DNA Modification Columns 25 Room Temp
Sufficient reagents are provided in the CpGenome Fast DNA Modification Kit to perform 25 bisulfite reactions.
* Wash Buffer requires the addition of 100% Ethanol.
90585 Binding Buffer 20 mL Room Temp
90586 Wash Buffer* 12 mL Room Temp
90587 Elution Buffer 1.5 mL Room Temp
90588 DNA Modification Columns 25 Room Temp
Sufficient reagents are provided in the CpGenome Fast DNA Modification Kit to perform 25 bisulfite reactions.
* Wash Buffer requires the addition of 100% Ethanol.
法律信息
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Li Sui et al.
Steroids, 75(12), 988-997 (2010-07-06)
Thyroid hormones have long been known to play important roles in the development and functions of the central nervous system, however, the precise molecular mechanisms that regulate thyroid hormone-responsive gene expression are not well understood. The present study investigated the
Jeung Il Kim et al.
Human pathology, 40(7), 934-941 (2009-04-10)
The DNA-repair protein O(6)-methylguanine-DNA methyltransferase removes alkyl adducts from the O(6)-position of guanine. The adducts can mispair with T during DNA replication, resulting in a G-to-A mutation. Epigenetic inactivation of O(6)-methylguanine-DNA methyltransferase has been found in human neoplasia and is
Soo Han Lee et al.
Histology and histopathology, 24(7), 831-838 (2009-05-29)
The biological characteristics of intestinal-type early gastric cancers (ICs) differ based on mucin phenotypes. Beta-catenin delocalization is a predictive marker of aggressive biological behavior (submucosal invasion and lymph node metastasis) of ICs. The presumptive causative genetic alterations leading to delocalization
P-H Su et al.
Oncogene, 32(1), 15-26 (2012-02-15)
Epigenetic modifications are a driving force in carcinogenesis. However, their role in cancer metastasis remains poorly understood. The present study investigated the role of DNA methylation in the cervical cancer metastasis. Here, we report evidence of the overexpression of DNA
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门